Deficiency of Rap1-Binding Protein RAPL Causes Lymphoproliferative Disorders through Mislocalization of p27kip1

Immunity

Volumn 34, Issue 1, 2011, Pages 24-38

  Katagiri, Koko ^a,b   Ueda, Yoshihiro ^b   Tomiyama, Takashi ^b   Yasuda, Kaneki ^b   Toda, Yoshinobu ^c   Ikehara, Susumu ^b   Nakayama, Keiichi I ^d   Kinashi, Tatsuo ^b  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; LYMPHOCYTE RECEPTOR; RAS RELATED PROTEIN1 BINDING PROTEIN; SERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B CELL LYMPHOMA; CELL CYCLE S PHASE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME KINETICS; ENZYME PHOSPHORYLATION; FEMALE; GLOMERULONEPHRITIS; INTRACELLULAR SIGNALING; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MOUSE; MUTATION; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; WILD TYPE;

ANIMALS; AUTOIMMUNITY; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; LUPUS NEPHRITIS; LYMPHOCYTES; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, KNOCKOUT; MUTATION; PHOSPHORYLATION; PROTEIN TRANSPORT; RAP1 GTP-BINDING PROTEINS;

EID: 78751704150     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2010.12.010     Document Type: Article

References (43)

1. Aleem E., Kiyokawa H., Kaldis P. Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat. Cell Biol. 2005, 7:831-836.
2. Appleman L.J., Berezovskaya A., Grass I., Boussiotis V.A. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J. Immunol. 2000, 164:144-151.
3. Avruch J., Xavier R., Bardeesy N., Zhang X.F., Praskova M., Zhou D., Xia F. Rassf family of tumor suppressor polypeptides. J. Biol. Chem. 2009, 284:11001-11005.
4. Baldassarre G., Belletti B., Nicoloso M.S., Schiappacassi M., Vecchione A., Spessotto P., Morrione A., Canzonieri V., Colombatti A. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 2005, 7:51-63.
5. Balomenos D., Martinez A.C. Cell-cycle regulation in immunity, tolerance and autoimmunity. Immunol. Today 2000, 21:551-555.
6. Barnouin K., Fredersdorf S., Eddaoudi A., Mittnacht S., Pan L.X., Du M.Q., Lu X. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells. Oncogene 1999, 18:6388-6397.
7. Bashir T., Dorrello N.V., Amador V., Guardavaccaro D., Pagano M. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 2004, 428:190-193.
8. Besson A., Gurian-West M., Chen X., Kelly-Spratt K.S., Kemp C.J., Roberts J.M. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev. 2006, 20:47-64.
9. Besson A., Hwang H.C., Cicero S., Donovan S.L., Gurian-West M., Johnson D., Clurman B.E., Dyer M.A., Roberts J.M. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev. 2007, 21:1731-1746.
10. Bhattacharjee R.N., Banks G.C., Trotter K.W., Lee H.L., Archer T.K. Histone H1 phosphorylation by Cdk2 selectively modulates mouse mammary tumor virus transcription through chromatin remodeling. Mol. Cell. Biol. 2001, 21:5417-5425.
11. Boehm M., Yoshimoto T., Crook M.F., Nallamshetty S., True A., Nabel G.J., Nabel E.G. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J. 2002, 21:3390-3401.
12. Bos J.L., de Rooij J., Reedquist K.A. Rap1 signaling: Adhering to new models. Nat. Rev. Mol. Cell Biol. 2001, 2:369-377.
13. Boussiotis V.A., Freeman G.J., Taylor P.A., Berezovskaya A., Grass I., Blazar B.R., Nadler L.M. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat. Med. 2000, 6:290-297.
14. Ebisuno Y., Katagiri K., Katakai T., Ueda Y., Nemoto T., Inada H., Nabekura J., Okada T., Kannagi R., Tanaka T., et al. Rap1 controls lymphocyte adhesion cascade and interstitial migration within lymph nodes in RAPL-dependent and -independent manners. Blood 2010, 115:804-814.
15. Ekholm S.V., Reed S.I. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. 2000, 12:676-684.
16. Fero M.L., Rivkin M., Tasch M., Porter P., Carow C.E., Firpo E., Polyak K., Tsai L.H., Broudy V., Perlmutter R.M., et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 1996, 85:733-744.
17. Hara T., Kamura T., Nakayama K., Oshikawa K., Hatakeyama S. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway. J. Biol. Chem. 2001, 276:48937-48943.
18. Ishida N., Kitagawa M., Hatakeyama S., Nakayama K. Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability. J. Biol. Chem. 2000, 275:25146-25154.
19. Ishida N., Hara T., Kamura T., Yoshida M., Nakayama K., Nakayama K.I. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 2002, 277:14355-14358.
20. Jacobs S.R., Michalek R.D., Rathmell J.C. IL-7 is essential for homeostatic control of T cell metabolism in vivo. J. Immunol. 2010, 184:3461-3469.
21. Katagiri K., Maeda A., Shimonaka M., Kinashi T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat. Immunol. 2003, 4:741-748.
22. Katagiri K., Ohnishi N., Kabashima K., Iyoda T., Takeda N., Shinkai Y., Inaba K., Kinashi T. Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nat. Immunol. 2004, 5:1045-1051.
23. Katagiri K., Imamura M., Kinashi T. Spatiotemporal regulation of the kinase Mst1 by binding protein RAPL is critical for lymphocyte polarity and adhesion. Nat. Immunol. 2006, 7:919-928.
24. Katagiri K., Katakai T., Ebisuno Y., Ueda Y., Okada T., Kinashi T. Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. EMBO J. 2009, 28:1319-1331.
25. Kawauchi T., Chihama K., Nabeshima Y., Hoshino M. Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration. Nat. Cell Biol. 2006, 8:17-26.
26. Kotake Y., Nakayama K., Ishida N., Nakayama K.I. Role of serine 10 phosphorylation in p27 stabilization revealed by analysis of p27 knock-in mice harboring a serine 10 mutation. J. Biol. Chem. 2005, 280:1095-1102.
27. Lawson B.R., Koundouris S.I., Barnhouse M., Dummer W., Baccala R., Kono D.H., Theofilopoulos A.N. The role of alpha beta+ T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus. J. Immunol. 2001, 167:2354-2360.
28. Lee J.G., Kay E.P. Two populations of p27 use differential kinetics to phosphorylate Ser-10 and Thr-187 via phosphatidylinositol 3-Kinase in response to fibroblast growth factor-2 stimulation. J. Biol. Chem. 2007, 282:6444-6454.
29. Li L., Iwamoto Y., Berezovskaya A., Boussiotis V.A. A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Nat. Immunol. 2006, 7:1157-1165.
30. Li W.Q., Jiang Q., Aleem E., Kaldis P., Khaled A.R., Durum S.K. IL-7 promotes T cell proliferation through destabilization of p27Kip1. J. Exp. Med. 2006, 203:573-582.
31. Macheiner D., Heller G., Kappel S., Bichler C., Stattner S., Ziegler B., Kandioler D., Wrba F., Schulte-Hermann R., Zochbauer-Muller S., Grasl-Kraupp B. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma. J. Hepatol. 2006, 45:81-89.
32. Nakamura S., Okinaka K., Hirano I., Ono T., Sugimoto Y., Shigeno K., Fujisawa S., Shinjo K., Ohnishi K. KIS induces proliferation and the cell cycle progression through the phosphorylation of p27Kip1 in leukemia cells. Leuk. Res. 2008, 32:1358-1365.
33. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., Loh D.Y. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996, 85:707-720.
34. Polyak K., Lee M.H., Erdjument-Bromage H., Koff A., Roberts J.M., Tempst P., Massague J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994, 78:59-66.
35. Qi C.F., Xiang S., Shin M.S., Hao X., Lee C.H., Zhou J.X., Torrey T.A., Hartley J.W., Fredrickson T.N., Morse H.C. Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B cell lymphomas. Leuk. Res. 2006, 30:153-163.
36. Raab M., Wang H., Lu Y., Smith X., Wu Z., Strebhardt K., Ladbury J.E., Rudd C.E. T cell receptor "inside-out" pathway via signaling module SKAP1-RapL regulates T cell motility and interactions in lymph nodes. Immunity 2010, 32:541-556.
37. Reynisdottir I., Massague J. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 1997, 11:492-503.
38. Rodier G., Montagnoli A., Di Marcotullio L., Coulombe P., Draetta G.F., Pagano M., Meloche S. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J. 2001, 20:6672-6682.
39. Semmrich M., Smith A., Feterowski C., Beer S., Engelhardt B., Busch D.H., Bartsch B., Laschinger M., Hogg N., Pfeffer K., Holzmann B. Importance of integrin LFA-1 deactivation for the generation of immune responses. J. Exp. Med. 2005, 201:1987-1998.
40. Sherr C.J., Roberts J.M. Cdk inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13:1501-1512.
41. Stork P.J., Dillon T.J. Multiple roles of Rap1 in hematopoietic cells: Complementary versus antagonistic functions. Blood 2005, 106:2952-2961.
42. Tan J.T., Dudl E., LeRoy E., Murray R., Sprent J., Weinberg K.I., Surh C.D. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 2001, 98:8732-8737.
43. Vos M.D., Martinez A., Ellis C.A., Vallecorsa T., Clark G.J. The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung. J. Biol. Chem. 2003, 278:21938-21943.